Pure Hospitality Solutions (OTC:PNOW) is developing efficient tools to enable travelers to book lodging accommodations in affordable high end luxury units at relatively low cost. To execute this mission, the company primarily focuses on the development and acquisition of condominium apartments in hot-spot tourist destinations like Costa Rica. Pure’s overarching mission is to compete alongside travel industry behemoths like Expedia, Inc. (NASDAQ:EXPE), Orbitz Worldwide, Inc. (NYSE:OWW) and Priceline Group, Inc. (PCLN).

In most cases, Pure uses its Friendly Reservations Online (FROL) booking engine to ensure higher occupancy rates in its affiliate condos and that of the individual owners. FROL is currently undergoing a pre-launch overhaul, in which the tool will be branded as an online travel agency (OTA) called Oveedia, which will focus on the Central American-Caribbean region.

Oveedia will be accessible on al devices, and will ultimately incorporate new mobile apps, offer travelers the newest electronic payment options, provide hotel operators and condominium owners with back-end technology services, and operate as a standalone online hospitality search and reservation booking system.

Bigger industry players like Expedia and Orbitz generally charge about 25% of the total reservation amount, according to Pure. These OTAs are essentially third-party travel sites offering virtual billboards to hotels and condominiums looking to market their properties to online travel shoppers. Because these OTAs have amassed high-volume traffic, they are in a position to command higher commission rates.

Pure’s plan is to leverage this OTA billboard model and maintain a competitive edge by offering its hospitality reservation services, utilizing its booking engine, at 8% of the reservation amount. While charging lower commission rates, the company will drive revenues through four key strategies:

1. Initial membership fees charged to each new hotel and condominium properties joining the “by PURE” lodging brand;
2. Monthly royalties from “by PURE” brand locations of no more than 8% of the total Internet reservation sales revenue;
3. Revenue generated from corporate-owned properties;
4. E-marketing revenue.

The company has already signed up a number of properties during past product beta test, and said it believes that through the post-merger/acquisition of various projects located in Costa Rica, it can attract, secure and successfully provide services to approximately 300 participating hotel and condominium owners within the next 12 months.

Ultimately, Pure intends to become a top-tier hotel brand operator and Internet booking and marketing service provider. The company also intends to establish an international footprint with its online booking engine technology and marketing offerings, making that segment of its business a prime acquisition target for major OTAs.

For more information visit www.purenow.solutions

Let us hear your thoughts: Oriens Travel and Hotel Management Corp. Message Board

Supertel Hospitality is a self-administered real estate investment trust that specializes in the ownership of select-service hotels. The company currently owns 49 hotels in 19 states that are operated by various third-party management companies – including Hilton Hotels and Resorts® (HLT), Choice Hotels® (CHH) and Wyndham® Hotels (WYN) – through franchise agreements.

In recent months, Supertel has initiated a new investment strategy involving upper midscale and upscale hotels in order to maximize shareholder returns in the future. In the first quarter of 2015, the company announced the sale of four hotels around the country for a cumulative sum of $7.5 million. In the second quarter, the company sold three additional properties for $9.3 million, and seven other hotels were also listed for sale as of March 31, 2015. With this influx of capital, Supertel has taken steps toward improving its balance sheet by repaying underlying loans. Following associated debt repayments, these sales are expected to generate approximately $14.5 million in net proceeds, which should enable the company to more effectively adhere to its updated investment strategy.

“The company is actively seeking acquisitions as we expand the efforts to recycle capital into newer hotels with higher margins in sectors and markets with characteristics having the potential to create higher shareholder value,” Bill Blackham, chief executive officer of Supertel, stated in a news release. “As this effort is underway, the underlying hotel portfolio appears to be on track to deliver an increased contribution and that should help to accelerate growing the company during this time of transition.”

Despite its transitional efforts, Supertel has realized noteworthy financial growth from its portfolio of properties in recent months. The company’s first quarter revenue from continuing operations was $12.3 million, which was a 9.3 percent year-over-year increase. Likewise, Supertel’s revenue per available room (RevPAR) improved by 9.9 percent to $35.19 for the period, outperforming the growth of the national hotel industry by nearly two percent.

As the global economy continues to recover moving forward, the hotel industry is expected to experience strong growth. According to a report by Statista, revenue generated by the global hotel industry is expected to climb to $550 billion in 2016, representing a 20 percent improvement over the results of 2011. For Supertel, this industry growth should provide a strong platform to post improved financial results. For prospective investors, the company’s recent efforts to increase shareholder value could foreshadow an opportunity to realize strong returns in the years to come.

For more information, visit www.supertelinc.com

Solaris Power Cells, Inc. (OTCQB: SPCL) is a diversified green energy storage manufacturer offering residential and commercial users turnkey, renewable energy solutions. The company’s proprietary Solaris Power Cell™ utilizes a printed circuit board assembly to provide lead-free, solid-state energy storage that’s both fully renewable and environmentally-friendly.

Although batteries are a common solution for the storage of renewable energy, these systems present engineers with a host of limitations – including short life cycles, high maintenance costs and negative environmental impact. The company’s power cell addresses these shortcomings through its innovative PESA™ (Passive Electron Storage Array). This system utilizes solar panels to charge the array, and, when renewable energy is no longer available, the PESA distributes its stored energy where it’s needed.

The potential market for Solaris’s groundbreaking energy storage system is vast, and it is expected to continue growing in the years to come. According to a report by research firm IHS, the global energy storage market is expected to reach six gigawatts in 2017, which would be an increase of more than 1,750 percent over 2013. Among this growth, the United States is expected to be the largest market for grid-connected energy storage installations.

Solaris also markets its PESA technology in an innovative e-cigarette application. Like all of the company’s products, the F-Series Vapor Mod operates battery-free, allowing for dramatically improved charging speeds and unparalleled lifecycle duration. In June, Solaris announced the release of its unique tobacco-alternative in four custom colors to capitalize on the sales potential presented by the rapidly expanding vaping market. According to The Smoke-Free Alternatives Trade Association, the e-cigarette industry is expected to exceed $10 billion by 2017.

Solaris is in a strong strategic position to make an impact in a variety of potentially lucrative market sectors. For prospective shareholders, Solaris’s innovative approach to the commercialization of its proprietary energy storage technology makes the company an intriguing investment opportunity moving forward.

For more information, visit www.solarispowercells.com

It’s been a busy week for technology innovator Net Element as the company issued a shareholder update, inclusive of the company’s recent financing of at least $10.5 million to sustain further expansion initiatives, as well news that its pending acquisition target has signed a contract to process transactions for several international dating networks.

Net Element leverages its core technology innovations and operational business partners to provide mobile payments and value-added transactional services in emerging countries and in the United States. To this accord, the company is continuously seeking out growth opportunities.

In its recent news release, Net Element defined its primary goal for the second half of 2015 as integrating PayOnline’s value-added technologies with Net Element’s current U.S. offerings to solidify its foothold as a premier payments-as-a-service company with a centralized, omni-channel global platform.

Upon closing of the acquisition, Net Element will be able to sell its mobile payment services to PayOnline’s more than 10 million active consumers and thousands of merchants in the Russian Federation, Europe and Asia.

“The acquisition of PayOnline will be transformative for the Company not only as a profitable acquisition but for the cutting edge payments tools it provides such as its recently announced availability of an online transactional platform for iOS apps (iPhone and iPad),” Net Element said in the news release.

PayOnline’s recent three-year contract centers on a minimum processing commitment of $300 million in transactions for social networks AnastasiaDate, AmoLatina and AsianDate, among others. Net Element currently manages, operates and is in the process of integrating the PayOnline group of companies pending closing of Net Element’s acquisition of the company.

The acquisition will add to Net Element’s current portfolio of subsidiaries, which include TOT Group, Inc., a global mobile payments and transaction processing provider whose companies include Unified Payments, Aptito and TOT Money, and emphasizes Net Element’s ability to facilitate cross-border transactions through a single interface.

“This contract win demonstrates our ability to quickly derive value from strategic acquisitions and partnerships,” Net Element CEO Oleg Firer stated in the news release. “As we emerge from a period of financial and business restructuring, we plan to see more such value driving developments as we progress into our growth phase.”

The financial restructuring mentioned by Firer, along with other achievements and the pending acquisition of PayOnline, triggered a reiterated 12-month price target of $5.17 per share by SeeThruEquity.

“Net Element has achieved several important developments since our last update in March 2015. Most importantly, Net Element made substantial progress shedding cumbersome debt on its balance sheet and announced a new $24.5mn capital raise. While improving its financial position, the company also reported double-digit annual growth in both 1Q15 and fiscal 2014 results and announced several growth initiatives for 2015 and beyond. The company also announced that it had executed definitive documentation for the acquisition of PayOnline, a leader in online transaction processing services and payment technology with over 10mn active consumers and thousands of merchants in the Russian Federation, Europe and Asia. We are reiterating our 12 month price target on NETE of $5.17 per share,” stated SeeThruEquity CEO Ajay Tandon.

Net Element is quick on its feet in taking advantage of opportunities that add momentum to grow revenues, by attracting more merchants to its payments platform, contributing to its overarching mission to become a competitive leader in mobile payments and transactional services in target countries and the United States.

For more information visit www.netelementinc.com

Bollente Companies, Inc. (OTCQB: BOLC), through its trutankless® brand, is a manufacturer and distributor of innovative tankless water heaters in the United States. The company strives to create electric tankless water heaters that far surpass traditional tank water heaters in terms of energy efficiency, output, dependability and environmental sustainability while effectively overcoming the drawbacks of lesser tankless units.

In April, Bollente announced the release of a new line of water heaters geared toward budget-driven customers. These products, known as the Vero™ line, boast the same unrivaled water heating performance, durability and space savings of the trutankless flagship line at a fraction of the cost. Following the enactment of updates to the National Appliance Energy Conservation Act earlier this year, Bollente expects this new product line to provide an opportunity for sustainable market growth in the future.

“The new Department of Energy guidelines for water heaters are going to impact the majority of homes that currently use traditional tank water heaters,” Michael Stebbins, president of trutankless, stated in a news release. “Tanks will become larger and costlier to install, and homes requiring tank heaters that hold 55 or more gallons will have to upgrade to a heat pump for twice the cost, or go tankless. We are pleased to offer whole-home electric tankless solutions that already exceed the new energy factor guidelines.”

The company’s product offerings also include truCirc, a state-of-the-art water circulation pump designed to work seamlessly with its efficient water heaters. truCirc allows users to accurately track water usage throughout their homes and predict when hot water will be needed. By learning usage patterns, the device limits energy usage by keeping water hot only when it is likely to be needed. The product’s intuitive interface also allows homeowners to quickly and easily change delivery modes and zones to minimize wasted water.

“As a standalone product, truCirc provides tremendous energy and water savings for a household,” continued Stebbins. “When used in conjunction with a 99 percent energy-efficient trutankless unit, the end result is a complete water heating system with unrivaled efficiency, durability and long-term value to the homeowner.”

As the home construction industry continues to shift toward more environmentally-friendly solutions, Bollente is in a strong strategic position to record improved financial results. According to a report by McGraw Hill Construction, the overall green single-family housing market is expected to account for more than $80 billion in revenue by 2016, representing a 100 percent increase over the results of 2013. This continued market growth could provide Bollente with an opportunity to post strong results in the future.

Bollente’s proven product line provides the company with a platform to realize continued growth in the months to come. For prospective investors, this growth could translate into sustainable returns moving forward.

For more information, visit www.bollentecompanies.com

BIO-key International, Inc. (OTCQB: BKYI) is a leading provider of advanced fingerprint biometric identification solutions to commercial and government enterprises, integrators and application developers. The company’s award-winning finger identification technology is currently used in some of the world’s largest identification deployments in order to improve security, guarantee identity and reduce identity theft. BIO-key’s software-based products are optimized to deliver fast and accurate user authentication on any device, network or internet environment, giving the company a highly scalable asset to promote future growth.

In March, the company expanded upon its existing product offerings through the announcement of EcoID, a compact USB touch fingerprint reader that delivers top quality identification at an unprecedented price point. With a manufacturer’s suggested retail price that’s substantially lower than other USB touch scanners, BIO-key will look to leverage this product in order to secure a larger share of the touch fingerprint reader market.

In May, BIO-key highlighted an additional, potentially expansive application for its technology when it announced a partnership with HealthCast, Inc. to deliver innovative solutions for single sign-on (SSO) and secure two-factor authentication for electronic prescription of controlled substances (EPCS) to clients across the United States. Potential customers include leading hospitals and hospital systems, such as Rady’s Children’s Hospital in San Diego, California, the first hospital in the country to deploy an EPCS solution utilizing the company’s proprietary EpicCare EMR technology.

“We understand that the doctors and nurses appreciate innovative technology that streamlines what was once a time-consuming and less secure process,” Jim Skidmore, vice president of sales at BIO-key, stated in a news release. “We are pleased to provide our solutions with those of HealthCast to meet these needs.”

Despite a decline in revenue during the first quarter of 2015, BIO-key is in a strong position to capitalize on the wide-spread potential applications of its technology in the months to come. By focusing its sales and marketing efforts on large enterprise and government opportunities, the company will look to achieve vastly increased revenue for the remaining quarters of 2015. In May, BIO-key reported a pipeline of sales opportunities valued at $30 million with which to promote this forecast financial growth.

“We made good progress across the business during the first quarter, helping to solidify our outlook for the balance of 2015 and beyond,” Michael DePasquale, chairman and chief executive officer of BIO-key, stated. “Though our first quarter sales performance fell below last year’s level… we are on target to achieve our full year revenue guidance of five to seven million dollars and expect to demonstrate the strength of our sales effort in our second quarter performance.”

For prospective investors, BIO-key’s recent progress toward expanding the market potential of its innovative biometric technology makes the company an intriguing option to consider moving forward. As it looks to convert upon the massive potential of its sales pipeline, look for BIO-key to take steps toward increasing its share of the domestic security software industry.

For more information, visit www.bio-key.com

DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) is a clinical and commercial stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of cancer. The company’s leading product candidate, VAL-083, is a first-in-class small molecule chemotherapeutic that is currently undergoing clinical trials in the United States as a potential treatment for refractory glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. Previously, the drug candidate has been the subject of extensive research by the U.S. National Cancer Institute, and it is currently approved for the treatment of chronic myelogenous leukemia (CML) and lung cancer in China.

In June, DelMar presented an update on its phase I/II clinical trial of VAL-083, and the initial results provide a promising outlook for the company. Despite having failed prior treatment with standard front-line options and having a growing GBM tumor at the time of enrollment in the DelMar clinical trial, 59 percent of patients treated with VAL-083 recorded better than average survival rates. With proper dosing, an improved median overall survival of about nine months was achieved, which marked a meaningful survival benefit over currently available treatment options.

“The overall survival demonstrated at the higher doses in our clinical trial with only two cycles of treatment is clinically meaningful in comparison to published outcomes in this patient population,” Jeffrey Bacha, president and chief executive officer of DelMar, stated in a news release. “We consider these results to be positive and supportive of the further development of VAL-083 as a potential new therapy for GBM patients who have failed other available treatments.”

In the months to come, DelMar will initiate activities to prepare for advancement to registration-directed phase II/III clinical trials of VAL-083. As the company approaches the eventual commercialization of its drug candidate, early results indicate that it could have the potential to replace temozolomide as the standard of care in newly-diagnosed GBM patients whose tumors express features correlated with resistance to standard chemotherapy.

The potential market for DelMar’s drug candidate upon commercialization with the United States is expansive. According to the American Brain Tumor Association, nearly 700,000 people in the U.S. are currently living with a brain tumor, and nearly 70,000 new cases are diagnosed each year. Among these cases, approximately 17 percent are related to GBM. By providing an improved therapeutic option to temozolomide-resistant GBM, the company is in a strong position to promote sustainable growth moving forward.

For prospective shareholders, DelMar’s continued progress toward the domestic commercialization of VAL-083 makes the company an intriguing investment option in the coming months.

For more information, visit www.delmarpharma.com

Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that provide unique and meaningful advantages to patients with renal disease. In December 2014, the company launched its first FDA-approved product, Auryxia™, in the United States for the treatment of elevated serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis. Keryx’s novel treatment is also being commercialized in Japan as Riona® for the treatment of patients with all stages of CKD by the company’s Japanese partner.

According to the National Kidney Foundation, approximately 26 million Americans currently suffer from kidney disease. Among those individuals, approximately 450,000 people are on dialysis treatments. For these people, maintaining serum phosphorus levels is imperative. An additional report by the National Kidney Foundation states that prolonged exposure to elevated phosphorus levels has been shown to cause increases in calcium-phosphate production, which is commonly associated with increased morbidity and, in many cases, mortality. This data highlights the immense market potential of Auryxia moving forward.

In the first quarter of 2015, Keryx leveraged the marketability of its groundbreaking product to record promising financial results. The company reported total revenue of approximately $1.2 million, including both U.S. product revenue and license revenue associated with sales of Riona in Japan. These figures are expected to rise in the future. In June, Keryx announced that Auryxia had been added to the Medicare Part D formularies of two national insurance providers, giving the company access to approximately 65 percent of people in the United States currently taking phosphate binders.

“The inclusion of Auryxia on the major insurance providers’ Part D formularies, which we expect will start processing claims in the third quarter, significantly expands unrestricted access to Auryxia for people on dialysis and their caregivers,” Greg Madison, chief executive officer of Keryx, stated in a news release. “Looking ahead, we are focused on continuing to raise awareness of Auryxia’s clinical profile among the prescribing community and ensuring that the vast majority of dialysis patients have access to this important medicine.”

In addition to plans of adding a team of field sales representatives in the months to come, the company’s short-term objectives include expanding the indication for Auryxia to include the treatment of iron deficiency anemia in patients with CKD. In September 2014, Keryx initiated a phase III study for this indication which is expected to be completed by the end of 2015.

For more information, visit www.keryx.com

Well Power’s attention is firmly on the ways it can help curb the flaring of wasted gas, a persistent and growing problem in the United States. To contribute in this area, the company gained an exclusive license to distribute ME Resources’ micro refinery unit (MRU) years ago and, since then, has been actively promoting this flare-reducing technology to potential investors and other interested parties.

As part of Well Power’s marketing efforts, companies involved in oil and gas production are invited to explore partnership opportunities with Well Power and learn more about the MRU which, once developed, is expected to process and transform wasted raw natural gas into electric power or engineered fuels. Although there are still some operational matters and regulatory changes to study, the successful development and deployment of a mobile, modular micro-refinery unit should create many lucrative opportunities for Well Power and ME Resources.

In addition, Well Power is bringing in new blood to continue to fuel its operations. Early this year, the company expanded its board of directors to include Robert V. Shields, an entrepreneur, professional engineer and petroleum industry veteran. Mr. Shields has been a professional engineer for more than 30 years. His petroleum industry experience is widespread and includes expertise in the areas of drilling, production operations, economic evaluations, identifying and securing international exploration mineral leases as well as raising equity capital from institutional investors in the United States and overseas.

Mr. Shields is a welcome addition to the Well Power team. His early years of employment include tenures with major oil and gas companies including Occidental International. He has extensive cross-cultural management experience as manager of drilling/production operations in Libya, Philippines, Brunei (offshore), the continental USA, Western Canada and the Canadian Arctic. Over 20 years, he also founded and became an owner/partner in four successful private oil companies which have collectively spent $C160 million and accrued a total exit value of approximately $C760 million. Additionally, in 2000, he co-discovered the largest conventional natural gas find in Canada, the Ladyfern field located in NE British Columbia. His combined experience in capital raising, engineering and entrepreneurship within the oil and gas industry will contribute vital insight to Well Power’s corporate goals and mission.

For more information, visit www.wellpowerinc.com

Let us hear your thoughts: Well Power Inc. Message Board

One World Holdings’ subsidiary is preparing to conduct a stockholders conference call next week on Wednesday, July 1 at 11:30 AM ET. The call will deliver an update on the national roll out of product in Wal-Mart Stores (NYSE: WMT) and plans for its business expansion.

Conference call speakers will include Ms. Joanne Melton, One World Holdings CEO and creator of the Prettie Girls! doll line, Ms. Stacey McBride-Irby. The call’s host will be Mr. Trent T. Daniel, Founder of The One World Doll Project.

Due to an anticipated large participant turn out, the call will run in listen-only mode. Those who wish to join should dial in at 712-432-0075 pin 278621# no later than 11:28 AM ET on Wednesday, July 1. The call will last approximately 45 minutes and a recording will be posted to the company website after the call.

The company’s thrust into the retail arena is providing OWOO the foundation it needs for generating its revenue base. At the beginning of Q3, the company announced a 532 percent increase in year-over-year revenue for 2014 while its national expansion puts One World in a strategically desirable position to build on this growth for the foreseeable future.

The Prettie Girls!™ represent a collection of fashion play dolls designed to give a sense and look of diversity in culture, style and interest. McBride-Irby, former Mattel® designer known for creating the company’s first African-American doll, designed the Prettie Girls! aimed at a growing market in need of a new type of experience. The Prettie Girls! take on the positive values and attributes that little girls can relate to and associate with.

For more information on the company, visit www.oneworlddolls.com

Let us hear your thoughts: One World Holdings Message Board